South Korea Completes First Joint Drug Review with EMA

South Korea's drug agency has successfully conducted its first joint review with the European Medicines Agency, aiming to streamline pharmaceutical approvals. This collaboration is expected to ease the regulatory burden on companies and enhance the global competitiveness of South Korean pharmaceutical firms. It reflects a growing trend towards international cooperation in drug regulation.